Microtest will also provide testing services to ImmusanT supporting its drug product manufacture, including method transfer activities, complete final product release testing, storage and stability. ImmusanT raised $20m
The oligoclonal therapeutic consists of a mixture of three fully human monoclonal antibodies which are designed to bind to non-overlapping epitopes of the epidermal growth factor receptor (EGFR).
The funding package includes a £2.5m loan along with ancillary facilities for four years through to December 2015. SEP is focused on marketing products related to urology and
The products are likely to be manufactured at Amerigen’s SFDA and US FDA approved finished dose plant in Suzhou, China, on receiving approval. The marketing and sales of
In the combination trial, patients will receive weekly intramuscular injections of ADI-PEG 20 until disease progression. The primary endpoints of the study are safety and efficacy, and secondary
As per the collaboration, Fosun Omni will use its expertise in formulation to develop products for Amerigen to commercialize in the US and other territories. Fosun Omni is
The extension will remain open while Hemispherx submits an amended NDA, the company said. In the request for extension, the company advised the FDA of the findings of
The financial terms of the current agreement have not been disclosed. The contract covers initial activities in developing a controlled release formulation of an undisclosed compound using the
According to the company, the combined use of these two drugs has recently been evaluated in animals and showed improved blood glucose regulation when compared to the administration
The new improved Columbus 2.3 system is believed to provide faster and more powerful high content analysis-based research applications. The platform will now help scientists perform their high
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.